GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NexgenRx Inc (OTCPK:NEGXF) » Definitions » Cyclically Adjusted Revenue per Share

NexgenRx (NexgenRx) Cyclically Adjusted Revenue per Share : $0.13 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is NexgenRx Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

NexgenRx's adjusted revenue per share for the three months ended in Mar. 2024 was $0.044. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.13 for the trailing ten years ended in Mar. 2024.

During the past 12 months, NexgenRx's average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of NexgenRx was 14.50% per year. The lowest was 9.10% per year. And the median was 11.05% per year.

As of today (2024-06-07), NexgenRx's current stock price is $0.19. NexgenRx's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.13. NexgenRx's Cyclically Adjusted PS Ratio of today is 1.46.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of NexgenRx was 4.00. The lowest was 1.33. And the median was 2.67.


NexgenRx Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for NexgenRx's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NexgenRx Cyclically Adjusted Revenue per Share Chart

NexgenRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.09 0.10 0.10 0.13

NexgenRx Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.11 0.11 0.13 0.13

Competitive Comparison of NexgenRx's Cyclically Adjusted Revenue per Share

For the Healthcare Plans subindustry, NexgenRx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NexgenRx's Cyclically Adjusted PS Ratio Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NexgenRx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where NexgenRx's Cyclically Adjusted PS Ratio falls into.



NexgenRx Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NexgenRx's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.044/126.2576*126.2576
=0.044

Current CPI (Mar. 2024) = 126.2576.

NexgenRx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.017 99.473 0.022
201409 0.017 99.394 0.022
201412 0.019 98.367 0.024
201503 0.017 99.789 0.022
201506 0.016 100.500 0.020
201509 0.015 100.421 0.019
201512 0.014 99.947 0.018
201603 0.018 101.054 0.022
201606 0.027 102.002 0.033
201609 0.018 101.765 0.022
201612 0.017 101.449 0.021
201703 0.018 102.634 0.022
201706 0.018 103.029 0.022
201709 0.023 103.345 0.028
201712 0.017 103.345 0.021
201803 0.017 105.004 0.020
201806 0.017 105.557 0.020
201809 0.019 105.636 0.023
201812 0.027 105.399 0.032
201903 0.026 106.979 0.031
201906 0.025 107.690 0.029
201909 0.024 107.611 0.028
201912 0.028 107.769 0.033
202003 0.029 107.927 0.034
202006 0.026 108.401 0.030
202009 0.028 108.164 0.033
202012 0.028 108.559 0.033
202103 0.030 110.298 0.034
202106 0.030 111.720 0.034
202109 0.032 112.905 0.036
202112 0.035 113.774 0.039
202203 0.033 117.646 0.035
202206 0.035 120.806 0.037
202209 0.036 120.648 0.038
202212 0.035 120.964 0.037
202303 0.033 122.702 0.034
202306 0.037 124.203 0.038
202309 0.038 125.230 0.038
202312 0.038 125.072 0.038
202403 0.044 126.258 0.044

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


NexgenRx  (OTCPK:NEGXF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

NexgenRx's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.19/0.13
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of NexgenRx was 4.00. The lowest was 1.33. And the median was 2.67.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


NexgenRx Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of NexgenRx's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


NexgenRx (NexgenRx) Business Description

Industry
Traded in Other Exchanges
Address
191 The West Mall, Suite 905, Toronto, ON, CAN, M9C 5L6
NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.